ATE475714T1 - Verfahren zur herstellung von glycoprotein mit menschlichem glycosylierungsbild - Google Patents

Verfahren zur herstellung von glycoprotein mit menschlichem glycosylierungsbild

Info

Publication number
ATE475714T1
ATE475714T1 AT99959703T AT99959703T ATE475714T1 AT E475714 T1 ATE475714 T1 AT E475714T1 AT 99959703 T AT99959703 T AT 99959703T AT 99959703 T AT99959703 T AT 99959703T AT E475714 T1 ATE475714 T1 AT E475714T1
Authority
AT
Austria
Prior art keywords
image
human glycosylation
glycoprotein
producing glycoprotein
plant cell
Prior art date
Application number
AT99959703T
Other languages
English (en)
Inventor
Tatsuji Seki
Kazuhito Fujiyama
Original Assignee
Phyton Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18411476&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE475714(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Phyton Holdings Llc filed Critical Phyton Holdings Llc
Application granted granted Critical
Publication of ATE475714T1 publication Critical patent/ATE475714T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0065—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8245—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01—Peroxidases (1.11.1)
    • C12Y111/01007—Peroxidase (1.11.1.7), i.e. horseradish-peroxidase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/01—Hexosyltransferases (2.4.1)
    • C12Y204/01038—Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (2.4.1.38)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Nutrition Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • Automatic Assembly (AREA)
AT99959703T 1998-12-09 1999-12-08 Verfahren zur herstellung von glycoprotein mit menschlichem glycosylierungsbild ATE475714T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP35058498 1998-12-09
PCT/JP1999/006881 WO2000034490A1 (en) 1998-12-09 1999-12-08 A method for manufacturing glycoproteins having human-type glycosylation

Publications (1)

Publication Number Publication Date
ATE475714T1 true ATE475714T1 (de) 2010-08-15

Family

ID=18411476

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99959703T ATE475714T1 (de) 1998-12-09 1999-12-08 Verfahren zur herstellung von glycoprotein mit menschlichem glycosylierungsbild

Country Status (16)

Country Link
US (5) US6998267B1 (de)
EP (2) EP2264177B1 (de)
JP (4) JP2002543760A (de)
AT (1) ATE475714T1 (de)
AU (1) AU771908C (de)
BR (1) BR9917026B1 (de)
CA (1) CA2354377C (de)
DE (1) DE69942636D1 (de)
DK (2) DK1137789T3 (de)
ES (2) ES2558160T3 (de)
IL (3) IL143641A0 (de)
MX (1) MXPA01005778A (de)
NZ (1) NZ512185A (de)
PT (1) PT1137789E (de)
WO (1) WO2000034490A1 (de)
ZA (1) ZA200104695B (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7378506B2 (en) * 1997-07-21 2008-05-27 Ohio University Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
US6639050B1 (en) 1997-07-21 2003-10-28 Ohio University Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
BR9917026B1 (pt) 1998-12-09 2010-10-19 método para fabricar glicoproteìnas tendo glicosilação do tipo humano.
WO2000061739A1 (fr) 1999-04-09 2000-10-19 Kyowa Hakko Kogyo Co., Ltd. Methode de regulation de l'activite d'une molecule immunologiquement fonctionnelle
AU1573601A (en) * 1999-10-21 2001-04-30 Monsanto Company Post-translational modification of recombinant proteins produced in plants
AU2006201405B2 (en) * 1999-10-26 2008-08-28 Stichting Dienst Landbouwkundig Onderzoek Mammalian-type glycosylation in plants
PT1228231E (pt) * 1999-10-26 2007-09-25 Plant Res Int Bv Glicosilação do tipo mamífero em plantas
AU2014240302B2 (en) * 1999-10-26 2017-06-29 Stichting Dienst Landbouwkundig Onderzoek Mammalian-type glycosylation in plants
FR2808286B1 (fr) * 2000-04-26 2004-12-17 Agronomique Inst Nat Rech Nouvelle glucosidase i de plante et son application a la production de proteines recombinantes a glycosylation modifiee
ATE309385T1 (de) * 2000-06-28 2005-11-15 Glycofi Inc Verfahren für die herstellung modifizierter glykoproteine
US7632983B2 (en) 2000-07-31 2009-12-15 Biolex Therapeutics, Inc. Expression of monoclonal antibodies in duckweed
AU2012200674B2 (en) * 2000-08-18 2014-04-24 Shire Human Genetic Therapies, Inc. High mannose proteins and methods of making high mannose proteins
US7138262B1 (en) * 2000-08-18 2006-11-21 Shire Human Genetic Therapies, Inc. High mannose proteins and methods of making high mannose proteins
US6946292B2 (en) 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
IL156879A0 (en) * 2001-01-19 2004-02-08 Dow Chemical Co Method for secretory production of glycoprotein having human-type sugar chain using plant cell
AU2007249159B2 (en) * 2001-01-19 2011-10-06 Phyton Holdings, Llc Method for secretory production of glycoprotein having human-type sugar chain using plant cell
US20050144670A1 (en) * 2001-03-06 2005-06-30 Kazuhito Fujiyama Plant cell having animal-type sugar chain adding function
MXPA04006357A (es) * 2001-12-27 2005-03-31 Glycofi Inc Metodos para disenar estructuras de carbohidrato del tipo de mamifero.
CN1665934B (zh) 2002-03-19 2010-05-26 国际植物研究所 GNTIII(UDP-N乙酰葡萄糖胺:β-D-甘露糖苷β(1,4)-N-乙酰葡萄糖胺基-转移酶III)在植物中的表达
US7601891B2 (en) * 2002-03-19 2009-10-13 Plant Research International B.V. Optimizing glycan processing plants
CL2003002461A1 (es) * 2002-11-27 2005-01-07 Dow Chemical Company Agroscien Inmunoglobulina que comprende al menos un glicano afucosilado, composicion que la contiene, secuencia nucleotidica y vector que la comprende, procedimiento para producir dicha inmunoglobulina en plantas.
US20060252120A1 (en) * 2003-05-09 2006-11-09 Kieliszewski Marcia J Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
WO2005069845A2 (en) * 2004-01-14 2005-08-04 Ohio University Methods of producing peptides/proteins in plants and peptides/proteins produced thereby
JP2007535317A (ja) * 2004-04-15 2007-12-06 グライコフィ， インコーポレイテッド 下等真核生物におけるガラクトシル化された糖タンパク質の産生
CA2573918A1 (en) 2004-04-19 2005-11-24 Ohio University Cross-linkable glycoproteins and methods of making the same
AU2005322617A1 (en) * 2004-12-23 2006-07-06 Glycofi, Inc. Immunoglobulins comprising predominantly a Ga1G1cNAcMan5GlcNAc2 glycoform
WO2007008708A2 (en) * 2005-07-08 2007-01-18 Ohio University Methods of predicting hyp-glycosylation sites for proteins expressed and secreted in plant cells, and related methods and products
CA2631948A1 (en) 2005-12-23 2007-07-05 James D. Kelly Improved thyroid-stimulating hormone receptor polypeptide agonist glycoforms to treat metabolic syndrome
NZ598048A (en) 2006-01-17 2013-05-31 Synthon Biopharmaceuticals Bv Compositions and methods for humanization and optimization of n-glycans in plants
US20090060921A1 (en) * 2006-01-17 2009-03-05 Biolex Therapeutics, Inc. Glycan-optimized anti-cd20 antibodies
SI1986612T1 (sl) 2006-02-07 2013-01-31 Shire Human Genetic Therapies, Inc. Stabilizirana spojina glukocerebrosidaze
EP1905826A1 (de) * 2006-09-29 2008-04-02 Universität für Bodenkultur Wien Galactosyltransferase
BRPI0810443A2 (pt) 2007-04-17 2016-09-27 Plant Res Int Bv glicosilação do tipo em mamífero em plantas através da expressão de glicosiltransferases de não mamíferos
EP2155880B1 (de) * 2007-06-15 2016-08-10 Medicago Inc. Modifikation der glykoproteinproduktion in pflanzen
JP2011115043A (ja) * 2008-03-27 2011-06-16 Japan Science & Technology Agency 植物においてｏ型糖鎖結合タンパク質を製造するためのキット及びその利用
JP5435535B2 (ja) * 2008-08-30 2014-03-05 独立行政法人産業技術総合研究所 植物における糖鎖構造の改変方法及びその植物体
WO2010105290A1 (en) 2009-03-16 2010-09-23 Cephalon Australia Pty Ltd Humanised antibodies with anti-tumour activity
NZ598156A (en) 2009-07-28 2014-06-27 Shire Human Genetic Therapies Compositions and methods for treating gaucher disease
CA2769473A1 (en) 2009-07-31 2011-02-03 N.V. Organon Fully human antibodies to btla
KR20120104558A (ko) 2009-11-05 2012-09-21 세파론 오스트레일리아 피티와이 엘티디 돌연변이형 ｋｒａｓ 또는 ｂｒａｆ 유전자를 포함하는 암을 치료하는 방법
US8715963B2 (en) 2010-02-24 2014-05-06 Merck Sharp & Dohme Corp. Method for increasing N-glycosylation site occupancy on therapeutic glycoproteins produced in Pichia pastoris
EP2595651B1 (de) 2010-07-19 2017-03-29 Shire Human Genetic Therapies, Inc. Kodonoptimierte zelllinie für den mannoserezeptor-c vom typ 1 (mrc1) und anwendungen davon
EA034989B1 (ru) 2011-10-28 2020-04-15 Тева Фармасьютикал Австралия Пти Лтд Полипептидная конструкция для применения при лечении рака, включающая аттенуированный альфа-интерферон
CA2865614A1 (en) 2012-03-02 2013-09-06 Shire Human Genetic Therapies, Inc. Compositions and methods for treating type iii gaucher disease
CA2909952C (en) 2013-04-29 2021-10-12 Teva Pharmaceuticals Australia Pty Ltd. Anti-cd38 antibodies and fusions to attenuated interferon alpha-2b
US11117975B2 (en) 2013-04-29 2021-09-14 Teva Pharmaceuticals Australia Pty Ltd Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B
JP2013143969A (ja) * 2013-04-30 2013-07-25 National Institute Of Advanced Industrial Science & Technology 植物における糖鎖構造の改変方法及びその植物体
JP2015177140A (ja) 2014-03-18 2015-10-05 日立オートモティブシステムズ株式会社 電子制御装置
UA119352C2 (uk) 2014-05-01 2019-06-10 Тева Фармасьютикалз Острейліа Пті Лтд Комбінація леналідоміду або помалідоміду і конструкції анти-cd38 антитіло-атенуйований інтерферон альфа-2b та спосіб лікування суб'єкта, який має cd38-експресуючу пухлину
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
SG11201703251TA (en) 2014-10-29 2017-05-30 Teva Pharmaceuticals Australia Pty Ltd INTERFERON α2B VARIANTS
JP6758388B2 (ja) 2015-10-12 2020-09-23 アプロゲン・ケーアイシー・インコーポレイテッドＡｐｒｏｇｅｎ Ｋｉｃ Ｉｎｃ． 抗−ｃｄ４３抗体およびその癌治療用途
EP3445393A4 (de) 2016-04-20 2020-08-05 Merck Sharp & Dohme Corp. Cmv-neutralisierende antigenbindende proteine
JP7241677B2 (ja) 2016-07-19 2023-03-17 テバ・ファーマシューティカルズ・オーストラリア・ピーティワイ・リミテッド 抗ｃｄ４７併用療法
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
TWI796329B (zh) 2017-04-07 2023-03-21 美商默沙東有限責任公司 抗－ilt4抗體及抗原結合片段
KR20210061341A (ko) 2018-09-13 2021-05-27 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 신규한 lilrb4 항체 및 이의 용도
JP7765397B2 (ja) 2020-03-12 2025-11-06 イミューン－オーエヌシー セラピューティクス，インコーポレーテッド 新規抗ｌｉｌｒｂ４抗体および派生産物
MX2022016322A (es) 2020-06-25 2023-01-24 Merck Sharp & Dohme Llc Anticuerpos de alta afinidad dirigidos a tau fosforilada en la serina 413.
WO2022120064A1 (en) 2020-12-03 2022-06-09 The Board Of Regents Of The University Of Texas System Methods for identifying lilrb-blocking antibodies

Family Cites Families (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB191401367A (en) 1914-01-17 1914-07-16 Guillaume Prist Security Seal for Packages, Waggons, Flagons, Cans and the like.
US3037905A (en) 1956-03-26 1962-06-05 Kendall & Co Fungicidal compounds, compositions thereof, and methods of utilizing same
JPS5455790A (en) 1977-10-05 1979-05-04 Tomoyuki Tajima Production of erythropoetin
JPS5616496A (en) 1979-07-20 1981-02-17 Sumitomo Chem Co Ltd Recovery of erythropoietin
JPS5653696A (en) 1979-10-09 1981-05-13 Ajinomoto Co Inc Isolation of erythropoietin by adsorption
JPS56108798A (en) 1980-02-01 1981-08-28 Green Cross Corp:The Purification of erythropoietin
JPS57149228A (en) 1981-03-11 1982-09-14 Ajinomoto Co Inc Novel erythropoietin and its preparation
JPS57169424A (en) 1981-04-10 1982-10-19 Toyo Shinyaku Kk Preparation of erythropoietin
JPS5910815A (ja) 1982-07-09 1984-01-20 Anritsu Corp 組合せ計量装置
JPS5964361U (ja) 1982-10-25 1984-04-27 トヨタ自動車株式会社 車両用ブレ−キのｘ配管式液圧装置
US4956282A (en) 1985-07-29 1990-09-11 Calgene, Inc. Mammalian peptide expression in plant cells
US5179198A (en) 1988-07-11 1993-01-12 Hidechika Okada Glycoprotein and gene coding therefor
US5202422A (en) * 1989-10-27 1993-04-13 The Scripps Research Institute Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins and method of their use
US5959177A (en) * 1989-10-27 1999-09-28 The Scripps Research Institute Transgenic plants expressing assembled secretory antibodies
WO1991016449A1 (en) 1990-04-16 1991-10-31 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
US5272070A (en) * 1991-03-08 1993-12-21 Board Of Regents, The University Of Texas System Method for the preparation of cell lines producing Man3 GlcNac 2 asparagine-linked gylcans and cell lines produced thereby
ATE210150T1 (de) 1991-04-18 2001-12-15 Toray Industries Verfahren zur herstellung von interleukin-6 zusammensetzungen
US5874271A (en) 1992-08-21 1999-02-23 Takara Shuzo Co., Ltd. Human glycosyltransferase gene, compounds and method for inhibiting cancerous metastasis
NZ258525A (en) 1992-11-27 1997-05-26 Ciba Geigy Ag Proteins with glycosyltransferase activity and their recombinant production
AU691510B2 (en) 1993-07-15 1998-05-21 Neose Pharmaceuticals Method of synthesizing saccharide compositions
WO1995018217A1 (en) 1993-12-24 1995-07-06 The Institute Of Physical And Chemical Research Novel sugar-chain synthetase and process for producing the same
JP2839232B2 (ja) * 1993-12-24 1998-12-16 理化学研究所 新規糖鎖合成酵素
JP2854803B2 (ja) * 1994-04-28 1999-02-10 理化学研究所 新規糖鎖合成酵素
AU1838495A (en) 1994-02-03 1995-08-21 Scripps Research Institute, The Method for using tobacco mosaic virus to overproduce peptides and proteins
US5723755A (en) 1995-05-16 1998-03-03 Francis E. Lefaivre Large scale production of human or animal proteins using plant bioreactors
US5939288A (en) 1995-06-07 1999-08-17 Iowa State University Research Foundation, Inc. Plant secretory signal peptides and nectarins
FR2736930B1 (fr) 1995-07-17 1997-09-19 Biocem Procede de production, par des cellules vegetales, de proteines heminiques, proteines ainsi obtenues et produits contenant ces proteines
AU6504796A (en) * 1995-07-20 1997-02-18 Washington State University Research Foundation Production of secreted foreign polypeptides in plant cell culture
DE69736261T2 (de) 1996-01-24 2007-06-06 Toyo Boseki K.K. Alpha-1-6-fucosyltransferasen
ATE374816T1 (de) * 1996-08-02 2007-10-15 Austin Research Inst Verbesserte nukleinsäuren, welche für eine chimäre glycosyltransferase kodieren
WO1998026053A1 (fr) * 1996-12-12 1998-06-18 Kirin Beer Kabushiki Kaisha NOUVELLE β1→4 N-ACETYLGLUCOSAMINYLTRANSFERASE ET GENE LA CODANT
ATE263841T1 (de) 1997-01-16 2004-04-15 Neose Technologies Inc Praktische in vitro sialylierung von rekombinanten glykpproteinen
US6087115A (en) 1997-01-22 2000-07-11 Cornell Research Foundation, Inc. Methods of identifying negative antagonists for G protein coupled receptors
JP3921271B2 (ja) 1997-05-16 2007-05-30 生化学工業株式会社 グルクロン酸転移酵素をコードするｄｎａ
JPH116881A (ja) 1997-06-16 1999-01-12 Citizen Watch Co Ltd 電子時計
JP4003093B2 (ja) 1997-07-29 2007-11-07 東洋紡績株式会社 糖類の製造方法
AU1585999A (en) 1997-11-12 1999-05-31 Neurotherapeutics Methods for the detection and treatment of disease using a glycosyltransferase
DE19754622A1 (de) * 1997-12-09 1999-06-10 Antje Von Dr Schaewen Pflanzliche GntI-Sequenzen und Verwendung derselben zur Gewinnung von Pflanzen mit verminderter oder fehlender N-Acetylglucosaminyltransferase I (GnTI)-Aktivität
FR2774379B1 (fr) 1998-01-30 2002-03-29 Groupe Limagrain Holding Procede de production, par des cellules vegetales, d'alpha 1-antitrypsine et de ses variantes, et produits contenant l'alpha-antitrypsine ainsi obtenue
US6096546A (en) 1998-01-30 2000-08-01 Board Of Trustees, Rutgers, The State University Of New Jersey Methods for recovering polypeptides from plants and portions thereof
US5955282A (en) 1998-04-03 1999-09-21 Incyte Pharmaceuticals, Inc. Human galactosyltransferases
PT1071700E (pt) 1998-04-20 2010-04-23 Glycart Biotechnology Ag Modificação por glicosilação de anticorpos para melhorar a citotoxicidade celular dependente de anticorpos
US6558934B1 (en) 1998-07-17 2003-05-06 Glycozm Aps UDP-galactose: β-N-acetyl-glucosamine β-1,4-galactosyl-transferase, β4Gal-T2
NO984968L (no) 1998-10-26 2000-04-27 Lmg Marin Anordning for posisjonering av fartøy
IL126967A (en) 1998-11-09 2002-09-12 Lightech Electronics Ind Ltd Electronic transformer for lighting
JP2002530087A (ja) 1998-11-18 2002-09-17 ネオーズ テクノロジーズ， インコーポレイテッド オリゴ糖の安価な産生
BR9917026B1 (pt) * 1998-12-09 2010-10-19 método para fabricar glicoproteìnas tendo glicosilação do tipo humano.
AT408446B (de) 1999-02-18 2001-11-26 Altmann Friedrich Dr Fucosyltransferase-gen
JP2000245470A (ja) * 1999-02-26 2000-09-12 Noda Inst For Scient Res 植物細胞間液による外来ポリペプチドの製造方法
JP2002537796A (ja) 1999-03-02 2002-11-12 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ヒトグリコシル化酵素
JP2000287692A (ja) 1999-04-09 2000-10-17 Mitsui Chemicals Inc 糖タンパク質の有するｎ−結合型糖鎖の組成中、分岐数が異なる糖鎖の含有割合を制御する方法
CA2387876A1 (en) 1999-10-15 2001-04-26 Calgene Llc Methods and vectors for site-specific recombination in plant cell plastids
AU1573601A (en) 1999-10-21 2001-04-30 Monsanto Company Post-translational modification of recombinant proteins produced in plants
AU1738301A (en) 1999-10-26 2001-05-08 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Gonadotrophins in plants
PT1228231E (pt) 1999-10-26 2007-09-25 Plant Res Int Bv Glicosilação do tipo mamífero em plantas
JP2001546898A (en) 1999-12-21 2003-06-10 Kyowa Hakko Kogyo Kk MODIFIED alpha -1,2-FUCOSYLTRANSFERASE GENE AND PROCESS FOR PRODUCING alpha -1,2-FUCOSYLTRANSFERASE AND FUCOSE-CONTAINING SUGAR CHAIN
FR2803307A1 (fr) 1999-12-30 2001-07-06 Centre Nat Rech Scient Lignees de lymphocytes t cd4 specifiques de type th1 et procede pour leur induction ex vivo
ATE461272T1 (de) 1999-12-30 2010-04-15 Knut Kleesiek Xylosyltransferase und isoformen
WO2001062912A2 (en) 2000-02-24 2001-08-30 University Of Guelph Method of modulating glycosylation pathways
US20020174453A1 (en) * 2001-04-18 2002-11-21 Henry Daniell Production of antibodies in transgenic plastids
AT409381B (de) 2000-03-03 2002-07-25 Gloessl Josef Dr Xylosyltransferase-gen
FR2808286B1 (fr) 2000-04-26 2004-12-17 Agronomique Inst Nat Rech Nouvelle glucosidase i de plante et son application a la production de proteines recombinantes a glycosylation modifiee
AU2001250573A1 (en) 2000-04-28 2001-11-12 Michel Xilinas Treatment of pathological conditions influenced by the action of matrix metalloproteinases (mmps) using phanquinone
WO2001088117A2 (en) 2000-05-12 2001-11-22 Neose Technologies, Inc. In vitro fucosylation recombinant glycopeptides
JP2002002091A (ja) 2000-06-16 2002-01-08 Asahi Glass Co Ltd 記録媒体および記録物
JP3643755B2 (ja) 2000-06-23 2005-04-27 フランスベッド株式会社 組立て式家具
ATE309385T1 (de) 2000-06-28 2005-11-15 Glycofi Inc Verfahren für die herstellung modifizierter glykoproteine
JP2002087692A (ja) 2000-09-08 2002-03-27 Tei Yasunaka 入り隅テープ貼付機
TW519716B (en) * 2000-12-19 2003-02-01 Tokyo Electron Ltd Wafer bias drive for a plasma source
IL156879A0 (en) * 2001-01-19 2004-02-08 Dow Chemical Co Method for secretory production of glycoprotein having human-type sugar chain using plant cell
US20050144670A1 (en) 2001-03-06 2005-06-30 Kazuhito Fujiyama Plant cell having animal-type sugar chain adding function
CA2838062C (en) 2001-08-03 2015-12-22 Roche Glycart Ag Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
US20030175755A1 (en) 2002-03-05 2003-09-18 Yoshihiro Abiko Method of collecting data for estimation of susceptibility to periodontal disease
US7601891B2 (en) 2002-03-19 2009-10-13 Plant Research International B.V. Optimizing glycan processing plants
CN1665934B (zh) * 2002-03-19 2010-05-26 国际植物研究所 GNTIII(UDP-N乙酰葡萄糖胺:β-D-甘露糖苷β(1,4)-N-乙酰葡萄糖胺基-转移酶III)在植物中的表达
CL2003002461A1 (es) * 2002-11-27 2005-01-07 Dow Chemical Company Agroscien Inmunoglobulina que comprende al menos un glicano afucosilado, composicion que la contiene, secuencia nucleotidica y vector que la comprende, procedimiento para producir dicha inmunoglobulina en plantas.
US20070214273A1 (en) 2006-03-10 2007-09-13 Pronto Networks Across firewall communication system and method
BRPI0810443A2 (pt) 2007-04-17 2016-09-27 Plant Res Int Bv glicosilação do tipo em mamífero em plantas através da expressão de glicosiltransferases de não mamíferos

Also Published As

Publication number Publication date
DK1137789T3 (da) 2010-11-08
JP2009028054A (ja) 2009-02-12
IL207261A0 (en) 2010-12-30
AU771908B2 (en) 2004-04-08
DE69942636D1 (de) 2010-09-09
AU1681300A (en) 2000-06-26
EP1137789A1 (de) 2001-10-04
EP1137789B1 (de) 2010-07-28
US6998267B1 (en) 2006-02-14
IL207261A (en) 2017-07-31
US7388081B2 (en) 2008-06-17
ES2350063T3 (es) 2011-01-17
AU771908C (en) 2005-03-10
CA2354377C (en) 2007-04-10
MXPA01005778A (es) 2003-07-21
EP2264177B1 (de) 2015-09-30
JP5947142B2 (ja) 2016-07-06
IL143641A (en) 2010-11-30
US20110070649A1 (en) 2011-03-24
CA2354377A1 (en) 2000-06-15
NZ512185A (en) 2004-02-27
JP2012223198A (ja) 2012-11-15
PT1137789E (pt) 2010-10-21
US20130040391A1 (en) 2013-02-14
WO2000034490A1 (en) 2000-06-15
US8853370B2 (en) 2014-10-07
ES2558160T3 (es) 2016-02-02
IL143641A0 (en) 2002-04-21
DK2264177T3 (en) 2016-01-11
US20080124798A1 (en) 2008-05-29
BR9917026A (pt) 2002-01-02
EP2264177A1 (de) 2010-12-22
JP2014054263A (ja) 2014-03-27
US20050143564A1 (en) 2005-06-30
ZA200104695B (en) 2002-02-27
JP2002543760A (ja) 2002-12-24
BR9917026B1 (pt) 2010-10-19
US8241909B2 (en) 2012-08-14

Similar Documents

Publication Publication Date Title
ATE475714T1 (de) Verfahren zur herstellung von glycoprotein mit menschlichem glycosylierungsbild
DE69711629D1 (de) Verfahren zur herstellung von polyol-fettsäure-polyestern unter verwendung atmosphärischen oder überatmosphärischen drucks
AR020735A1 (es) Un procedimiento para la obtencion de un polipeptido glucosilado a partir de celulas eucarioticas
DE3884435D1 (de) Verfahren zur erzeugung hochreinen wassers und verfahren zur verwendung dieses wassers.
ATE313619T1 (de) Bioreaktor für die kultivierung von mikroorganismen sowie verfahren zur herstellung desselben
DE3863463D1 (de) Wasserabweisende faellungskieselsaeure, verfahren zu ihrer herstellung und deren anwendung zur verstaerkung von silikon-elastomeren.
ATE438722T1 (de) Verfahren zur herstellung von proteinen unter reduktion von mannosephosphat in der zuckerkette und dadurch hergestelltes glykoprotein
ATE334136T1 (de) Verfahren zur herstellung von azithromycin
DE69522479D1 (de) Verfahren zur herstellung von terephtalischer säure
DE3587377D1 (de) Verfahren zur herstellung von halbleiteranordnungen unter verwendung von silizium-auf- isolator techniken.
DE68925138D1 (de) Verfahren zur Herstellung von Proteinen durch Verwendung von CKS-Fusionsproteinen
DE3688336D1 (de) Verfahren zur herstellung von organischen saeuren unter verwendung von mikroorganismen.
EP0818138A4 (de) Verfahren zur herstellung einer osmotischen-druck-toleranten pflanze
DE59913565D1 (de) Rekombinanter stabiler zellklon, seine herstellung und verwendung
DE3789678D1 (de) Herstellung von erythropoietinproduzierenden Zellen und Verfahren zur Herstellung von Erythropoietin mit Verwendung dieser Zellen.
DE69637510D1 (de) Verfahren zur herstellung temperatur-toleranter pflanzen
ATE204283T1 (de) Verfahren zur herstellung von 2,2- difluorketensilylacetalen und alpha,alpha-difluor-beta -silyloxy-1,3-dioxolan-4-propansäureestern
DE3576361D1 (de) Rekombinante dna, damit transformierter mikroorganismus, und verfahren zur herstellung von menschlicher cu-zn superoxiddismutase unter verwendung des transformierten mikroorganismus.
DE68904625D1 (de) Verfahren zur herstellung von wasserstoffperoxid.
ATE135047T1 (de) Verfahren zur herstellung optisch aktiver cyanhydrine durch enzyme
DE69034128D1 (de) Saccharose-Phosphat-Synthase (SPS), ihr Verfahren zur Herstellung, ihr cDNA und Verwendung von cDNA zur Veränderung der SPS-Expression in Pflanzenzellen
ATE313632T1 (de) Durch pflanzen hergestellte rekombinante preduodenale lipase und abgeleitete polypeptide, verfahren zur herstellung und ihre verwendung
ATE196165T1 (de) Methoden zur herstellung von protein c
ATE186045T1 (de) Verfahren zur herstellung einer organischen säure
DE69010256D1 (de) Verfahren zur Herstellung von L-Ornithin durch Fermentation.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1137789

Country of ref document: EP